BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1301 related articles for article (PubMed ID: 33393485)

  • 21. Allergy to COVID-19 vaccines: A current update.
    Cabanillas B; Novak N
    Allergol Int; 2021 Jul; 70(3):313-318. PubMed ID: 33962863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine allergy: evidence to consider for COVID-19 vaccines.
    Nilsson L; Csuth Á; Storsaeter J; Garvey LH; Jenmalm MC
    Curr Opin Allergy Clin Immunol; 2021 Aug; 21(4):401-409. PubMed ID: 34091550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't.
    Malek AE; Cornejo PP; Daoud N; Alam M
    Immunotherapy; 2022 Feb; 14(2):91-94. PubMed ID: 34747190
    [No Abstract]   [Full Text] [Related]  

  • 24. COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.
    Peter J
    S Afr Med J; 2021 Feb; 111(4):291-294. PubMed ID: 33944757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How can countries stretch COVID vaccine supplies? Scientists are divided over dosing strategies.
    Ledford H
    Nature; 2021 Jan; 589(7841):182. PubMed ID: 33437062
    [No Abstract]   [Full Text] [Related]  

  • 26. UK science advisers: publish evidence behind COVID vaccine changes.
    Nature; 2021 Jan; 589(7841):169-170. PubMed ID: 33437064
    [No Abstract]   [Full Text] [Related]  

  • 27. Could mixing COVID vaccines boost immune response?
    Ledford H
    Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
    [No Abstract]   [Full Text] [Related]  

  • 28. [The Saga of Vaccines against Covid-19].
    Saliou P
    Bull Soc Pathol Exot; 2020; 113(4):185-186. PubMed ID: 33826275
    [No Abstract]   [Full Text] [Related]  

  • 29. [Not Available].
    Meylan P
    Rev Med Suisse; 2020 Oct; 16(709):1895. PubMed ID: 33026736
    [No Abstract]   [Full Text] [Related]  

  • 30. [Vaccination immunology in SARS-CoV-2].
    Helweg-Larsen J; Benfield T
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies.
    Sánchez-Zuno GA; Matuz-Flores MG; González-Estevez G; Nicoletti F; Turrubiates-Hernández FJ; Mangano K; Muñoz-Valle JF
    Int J Immunopathol Pharmacol; 2021; 35():20587384211050199. PubMed ID: 34632844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal COVID-19, vaccination safety in pregnancy, and evidence of protective immunity.
    Pham A; Aronoff DM; Thompson JL
    J Allergy Clin Immunol; 2021 Sep; 148(3):728-731. PubMed ID: 34314761
    [No Abstract]   [Full Text] [Related]  

  • 33. Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy.
    Soeiro T; Salvo F; Pariente A; Grandvuillemin A; Jonville-Béra AP; Micallef J
    Therapie; 2021; 76(4):365-367. PubMed ID: 33858693
    [No Abstract]   [Full Text] [Related]  

  • 34. One Shot Wonder: A Vaccine Against All Coronaviruses.
    Mertz L
    IEEE Pulse; 2020; 11(6):2-5. PubMed ID: 33315546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What scientists do and don't know about the Oxford-AstraZeneca COVID vaccine.
    Mallapaty S; Callaway E
    Nature; 2021 Apr; 592(7852):15-17. PubMed ID: 33762708
    [No Abstract]   [Full Text] [Related]  

  • 36. Bilateral Acute Macular Neuroretinopathy After Vaccination Against SARS-CoV-2.
    Book BAJ; Schmidt B; Foerster AMH
    JAMA Ophthalmol; 2021 Jul; 139(7):e212471. PubMed ID: 34287612
    [No Abstract]   [Full Text] [Related]  

  • 37. How to redesign COVID vaccines so they protect against variants.
    Callaway E; Ledford H
    Nature; 2021 Feb; 590(7844):15-16. PubMed ID: 33514888
    [No Abstract]   [Full Text] [Related]  

  • 38. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
    Schulze-Koops H; Specker C; Skapenko A
    RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant vaccines for COVID-19.
    Yadav T; Srivastava N; Mishra G; Dhama K; Kumar S; Puri B; Saxena SK
    Hum Vaccin Immunother; 2020 Dec; 16(12):2905-2912. PubMed ID: 33232211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunity to glycan α-Gal and possibilities for the control of COVID-19.
    la Fuente J; Gortázar C; Cabezas-Cruz A
    Immunotherapy; 2021 Feb; 13(3):185-188. PubMed ID: 33307805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.